Showing results (371-380 of 587) with videos related to
Sort By:
Pageof 59
Clinical Lung Cancer|April 8, 2023
A Patient-Centered Model of Fast-Track Lung Cancer DiagnosisPauline Pradere, Caroline Caramella, Fares Ben Salem, et al.Journal for Immunotherapy of Cancer|September 7, 2023
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancerPierre Decazes, Samy Ammari, Younes Belkouchi, et al.Lung Cancer (Amsterdam, Netherlands)|June 18, 2011
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerRadj Gervais, John D Hainsworth, Normand Blais, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2026
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLCSandra Ortiz-Cuaran, Laurine Dupriez, Constance Nicq, et al.Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspectiveVéronique Hofman, Guylène Rignol, Baharia Mograbi, et al.Cancers|April 12, 2022
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 StudyRenaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2021
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLCJyoti Malhotra, Petros Nikolinakos, Ticiana Leal, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2019
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLCTodd M Bauer, Benjamin Besse, Alex Martinez-Marti, et al.JTO Clinical and Research Reports|September 30, 2021
Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung TrialJordi Remon, Benjamin Besse, Alexandra Leary, et al.Cancer Treatment and Research Communications|July 29, 2022
Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancersTiphaine Lambert, Cedric Pobel, Léo Colmet-Daage, et al.Pageof 59